Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01779817
Other study ID # PHRC 2011-01
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date February 2013
Est. completion date January 2019

Study information

Verified date June 2018
Source University Hospital, Angers
Contact Natacha BOUHOURS-NOUET
Email NaBouhours-Nouet@chu-angers.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

1. MAIN OBJECTIVE :

To assess the consequences of a maternal hyperthyroïd during pregnancy on intellectual development of the child from 6 to 9 years

2. SECONDARY OBJECTIVES :

1. To assess the consequences of a maternal hyperthyroïd during pregnancy on the capacities of attention, learning process and the degree of hyperactivity of the child from 6 to 9 years.

2. To study if it exist differences of intellectual development, capacities of attention, learning process, and degree of hyperactivity in the child from 6 to 9 years, born to hyperthyroid mother during pregnancy, according to:

- the etiology of the maternal hyperthyroïd (transitory gestation hyperthyroid versus disease of Basedow),

- the use or not of a anti-thyroid treatment,

- the rate of TSH néonatal (measured with the blotter by tracking with J3 at all the new born ones).


Description:

1. INCLUSION CRITERIA :

- Old from 6 to 9 years included

- Age of gestation between ≥37 and <41 weeks of amenorrhoea

- Born from a mono-foetale pregnancy

- Euthyroïd at the time of the entry in the study

- Provided education for at the elementary school on a level adapted to its age

2. NON INCLUSION CRITERIA :

- Presenting a congenital hypothyroïd or a known thyroid dysfonction at the time of the entry in the study

- Carrier of a chronic pathology (organic or psychological) or malformative severe

- Presenting an antecedent of Deficit of the Attention-Hyperactivity to the 1st degree

3. EXCLUSION CRITERIA :

o Discovered of a thyroid dysfonction at the time of the entry in the study

4. STRATEGIES / PROCEDURES :

Multicentric, comparative study of a troop of child born to hyperthyroïd mothers during pregnancy (children exposed to the maternal hyperthyroïd) and children born to euthyroïd mothers during pregnancy (nonexposed children with the maternal hyperthyroïd).

- 1st part of the study: Retrospective analyze of the files of symptomatic hyperthyroid mothers during pregnancy.

- 2nd part of the study: Assessment of intellectual development, capacities of attention, learning process and degree of hyperactivity of the children between 6 and 9 years. The exposed children (born to hyperthyroïd mothers during pregnancy) will be compared with nonexposed children (born to euthyroïd mothers during pregnancy).


Recruitment information / eligibility

Status Recruiting
Enrollment 252
Est. completion date January 2019
Est. primary completion date January 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 9 Years
Eligibility 1. Inclusion Criteria:

A-For the child born to hyperthyroid mother during pregnancy :

oOld from 6 to 9 years included oAge of gestation between =37 and <41 weeks of amenorrhoea oBorn from a mono-foetale pregnancy oEuthyroïd at the time of the entry in the study oProvided education for at the elementary school on a level adapted to its age

B-For hyperthyroid mother during pregnancy :

oHyperthyroïd during pregnancy (transitory gestation hyperthyroid or disease of Basedow) oEuthyroïd at the time of the entry in the study

C-For the child born to euthyroid mother during pregnancy :

oOld from 6 to 9 years included oAge of gestation between =37 and <41 weeks of amenorrhoea oBorn from a mono-foetale pregnancy oEuthyroïd at the time of the entry in the study oProvided education for at the elementary school on a level adapted to its age

D-For euthyroid mother during pregnancy :

Euthyroïd at the time of the entry in the study

2. Exclusion Criteria:

A-For the child born to hyperthyroid mother during pregnancy :

Discovered of a thyroid dysfonction at the time of the entry in the study

B-For hyperthyroid mother during pregnancy:

Discovered of a thyroid dysfonction at the time of the entry in the study

C-For the child born to euthyroid mother during pregnancy:

Discovered of a thyroid dysfonction at the time of the entry in the study

D-For euthyroid mother during pregnancy:

oDiscovered of a thyroid dysfonction at the time of the entry in the study oCarrying anti-TPO antibody at the time of the entry in the study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Assessment of intellectual development, capacities of attention, learning process and degree of hyperactivity of the children between 6 and 9 years.


Locations

Country Name City State
France University Hospital of Amiens Amiens
France University Hospital of Angers Angers
France Civil Hospices of Lyon Bron
France University Hospital of Kremlin Bicetre Le Kremlin Bicetre
France University Hospital of Lille Lille
France University Hospital of Marseille Marseille
France University Hospital of Nantes Nantes
France Hospital of Saint Antoine Paris
France University Hospital of Cochin Paris
France University Hospital of Poitiers Poitiers
France University Hospital of Reims Reims
France University Hospital of Strasbourg Strasbourg
France University Hospital of Toulouse Toulouse

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Angers

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Scores of global development Quotient (WISC-R) within the first 30 days after inclusion of the patient
Secondary Score of the Achenbach Child Behavior Checklist within the first 30 days after inclusion of the patient
Secondary Score of the conners scale within the first 30 days after inclusion of the patient
Secondary Score of the Wechsler Intelligence Scale for Children (WISC-IV) within the first 30 days after inclusion of the patient